πŸ‡ΊπŸ‡Έ FDA
Patent

US 9243055

HERV-K antigens, antibodies, and methods

granted A61KA61K2039/505A61K2239/49

Quick answer

US patent 9243055 (HERV-K antigens, antibodies, and methods) held by The Board of Regents of the University of Texas System expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K2239/49, A61K40/11, A61K40/19